Dario Tuccinardi
Overview
Explore the profile of Dario Tuccinardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ernesti I, Massari M, Cipriani F, Masi D, Glaser K, Genco M, et al.
Diabetes Obes Metab
. 2025 Jan;
27(4):1950-1959.
PMID: 39791264
Aims: To date, bariatric surgery (BS) is the most effective long-term treatment for obesity, but weight regain (WR) is common. The very low-calorie ketogenic diet (VLCKD) is effective for weight...
2.
Rossetti R, Strinati V, Caputi A, Risi R, Spizzichini M, Mondo A, et al.
Metabolites
. 2024 Dec;
14(12).
PMID: 39728472
: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of fertile age. Some studies suggest that a ketogenic diet (KD) may have a role in treating PCOS....
3.
Colangeli L, Russo B, Capristo E, Mariani S, Tuccinardi D, Manco M, et al.
Front Endocrinol (Lausanne)
. 2024 Jul;
15:1434360.
PMID: 39076509
Introduction: Patient engagement is essential to achieve long-term goals in obesity management. It is crucial to identify patients' perspectives, misperceptions and unmet educational needs on obesity etiology and treatments, to...
4.
Tuccinardi D, Watanabe M, Masi D, Monte L, Meffe L, Cavallari I, et al.
Eur J Prev Cardiol
. 2024 Jun;
31(10):1260-1273.
PMID: 38833329
The global escalation of obesity has made it a worldwide health concern, notably as a leading risk factor for cardiovascular disease (CVD). Extensive evidence corroborates its association with a range...
5.
Maddaloni E, Tuccinardi D
Expert Rev Endocrinol Metab
. 2024 May;
19(4):295-297.
PMID: 38709217
No abstract available.
6.
Rossini G, Risi R, Monte L, Sancetta B, Quadrini M, Ugoccioni M, et al.
Diabetes Metab Res Rev
. 2023 Nov;
40(2):e3750.
PMID: 38018334
Post-bariatric hypoglycaemia (PBH) is a metabolic complication of bariatric surgery (BS), consisting of low post-prandial glucose levels in patients having undergone bariatric procedures. While BS is currently the most effective...
7.
Biagi F, Carlomagno F, Carbone M, Veralli R, Vespasiani-Gentilucci U, Riva E, et al.
Metabolites
. 2023 Nov;
13(11).
PMID: 37999215
Fibroblast growth factor 21 (FGF-21), previously recognized as a marker of liver damage and a potential drug target in non-alcoholic fatty liver disease (NAFLD), has unclear implications in hepatitis C...
8.
Defeudis G, Mazzilli R, Benvenuto D, Ciccozzi M, Di Tommaso A, Faggiano A, et al.
Hormones (Athens)
. 2023 May;
22(3):389-394.
PMID: 37231315
Purpose: Women with type 1 diabetes mellitus (T1D), especially those with suboptimal glucose control, have 3-4 greater chances of having babies with birth defects compared to healthy women. We aimed...
9.
Ernesti I, Baratta F, Watanabe M, Risi R, Camajani E, Persichetti A, et al.
Front Nutr
. 2023 Feb;
10:1058364.
PMID: 36761216
Introduction: The Very Low-Calorie Ketogenic Diet (VLCKD) has emerged as a safe and effective intervention for the management of metabolic disease. Studies examining weight loss predictors are scarce and none...
10.
Risi R, Rossini G, Tozzi R, Pieralice S, Monte L, Masi D, et al.
Surg Obes Relat Dis
. 2022 Jun;
18(7):983-996.
PMID: 35668018
With the prevalence of obesity alarmingly increasing, it is of primary interest to identify those factors predicting the success of anti-obesity therapeutic strategies currently adopted in clinical practice, and in...